Found: 688
Select item for more details and to access through your institution.
Patient-reported burden in adults with atopic dermatitis: an international qualitative study.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03130-w
- By:
- Publication type:
- Article
651 - Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.030
- By:
- Publication type:
- Article
729 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.102
- By:
- Publication type:
- Article
649 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.028
- By:
- Publication type:
- Article
667 - Maintenance of efficacy and safety with nemolizumab at week 48: results from two global phase 3 pivotal studies (ARCADIA-1 and ARCADIA-2) in patients with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.041
- By:
- Publication type:
- Article
668 - Improvements in itch and sleep disturbance are maintained up to week 48 with nemolizumab plus TCS/TCI treatment in patients with moderate-to-severe atopic dermatitis: results from two global phase 3 pivotal studies (ARCADIA 1 and ARCADIA 2).
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.042
- By:
- Publication type:
- Article
690 - SCORAD severity band threshold analysis from dupilumab clinical trials in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.064
- By:
- Publication type:
- Article
Novel Detection of Pleomorphic Adenomas via Analysis of 68 Ga-DOTATOC PET/CT Imaging.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2624, doi. 10.3390/cancers16152624
- By:
- Publication type:
- Article
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2249, doi. 10.1007/s13555-024-01226-9
- By:
- Publication type:
- Article
Patients' Reflections on Treatment Decision After Surgery for Laryngeal Cancer.
- Published in:
- JAMA Otolaryngology-Head & Neck Surgery, 2024, v. 150, n. 8, p. 666, doi. 10.1001/jamaoto.2024.1422
- By:
- Publication type:
- Article
Automated intracranial vessel segmentation of 4D flow MRI data in patients with atherosclerotic stenosis using a convolutional neural network.
- Published in:
- Frontiers in Radiology, 2024, p. 1, doi. 10.3389/fradi.2024.1385424
- By:
- Publication type:
- Article
Assessing the role of advanced artificial intelligence as a tool in multidisciplinary tumor board decision-making for primary head and neck cancer cases.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1353031
- By:
- Publication type:
- Article
Sailing the Seven Seas: A Multinational Comparison of ChatGPT's Performance on Medical Licensing Examinations.
- Published in:
- Annals of Biomedical Engineering, 2024, v. 52, n. 6, p. 1542, doi. 10.1007/s10439-023-03338-3
- By:
- Publication type:
- Article
Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 6, p. 1561, doi. 10.1007/s13555-024-01171-7
- By:
- Publication type:
- Article
The introduction of bedside ex vivo confocal microscopy during Mohs surgery of basal cell carcinoma: Patient and specialist benefit in an optimized healthcare environment.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 6, p. e465, doi. 10.1111/jdv.19651
- By:
- Publication type:
- Article
A large language model artificial intelligence for patient queries in atopic dermatitis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 6, p. e531, doi. 10.1111/jdv.19737
- By:
- Publication type:
- Article
OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 3, p. 447, doi. 10.1007/s40257-023-00838-9
- By:
- Publication type:
- Article
Correction to: OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Atopic dermatitis: A global health perspective.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 5, p. 801, doi. 10.1111/jdv.19723
- By:
- Publication type:
- Article
Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70‐Derived Peptide: A Combined Computational and Experimental Study.
- Published in:
- Advanced Science, 2024, v. 11, n. 14, p. 1, doi. 10.1002/advs.202305998
- By:
- Publication type:
- Article
Apiospora arundinis, a panoply of carbohydrate-active enzymes and secondary metabolites.
- Published in:
- IMA Fungus, 2024, v. 15, n. 1, p. 1, doi. 10.1186/s43008-024-00141-0
- By:
- Publication type:
- Article
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 483, doi. 10.1007/s40262-024-01352-9
- By:
- Publication type:
- Article
Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 4, p. 695, doi. 10.1111/jdv.19669
- By:
- Publication type:
- Article
Head and neck cancer of unknown primary: unveiling primary tumor sites through machine learning on DNA methylation profiles.
- Published in:
- Clinical Epigenetics, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13148-024-01657-3
- By:
- Publication type:
- Article
The Burden of Pediatric Atopic Dermatitis: Quality of Life of Patients and Their Families.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1700, doi. 10.3390/jcm13061700
- By:
- Publication type:
- Article
Environmental factors influence cross-talk between a heat shock protein and an oxidative stress protein modification in the lizard Gallotia galloti.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0300111
- By:
- Publication type:
- Article
Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 3, p. 272, doi. 10.1007/s11912-024-01506-9
- By:
- Publication type:
- Article
ChatGPT's Response Consistency: A Study on Repeated Queries of Medical Examination Questions.
- Published in:
- European Journal of Investigation in Health, Psychology & Education (EJIHPE), 2024, v. 14, n. 3, p. 657, doi. 10.3390/ejihpe14030043
- By:
- Publication type:
- Article
Phototherapy for atopic dermatitis: A survey of European practice.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 3, p. 521, doi. 10.1111/jdv.19638
- By:
- Publication type:
- Article
Brief Communication: The Predictable Network Topology of Evolutionary Genomic Constraint.
- Published in:
- Molecular Biology & Evolution, 2024, v. 41, n. 3, p. 1, doi. 10.1093/molbev/msae033
- By:
- Publication type:
- Article
Exposure to Plasticiser DEHP Affects Eggs Spawned by Blue Mussels: A Possible Risk to Fertilisation?
- Published in:
- Toxics, 2024, v. 12, n. 3, p. 172, doi. 10.3390/toxics12030172
- By:
- Publication type:
- Article
Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Conjunctivitis does not increase with longer duration of lebrikizumab exposure in patients with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii5, doi. 10.1093/bjd/ljad498.007
- By:
- Publication type:
- Article
Incidence of venous thromboembolic events and atherosclerotic cardiovascular disease risk factors in adolescents and adults with atopic dermatitis in Denmark: a population-based cohort study.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii36, doi. 10.1093/bjd/ljad498.038
- By:
- Publication type:
- Article
Tralokinumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients aged 12 years and older with and without atopic comorbidities.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii46, doi. 10.1093/bjd/ljad498.048
- By:
- Publication type:
- Article
Laboratory parameters in adolescent patients aged 12-17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii47, doi. 10.1093/bjd/ljad498.049
- By:
- Publication type:
- Article
Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii49, doi. 10.1093/bjd/ljad498.051
- By:
- Publication type:
- Article
Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii52, doi. 10.1093/bjd/ljad498.054
- By:
- Publication type:
- Article
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 1, p. 139, doi. 10.1007/s40257-023-00817-0
- By:
- Publication type:
- Article
Treat‐to‐target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 1, p. 42, doi. 10.1111/jdv.19506
- By:
- Publication type:
- Article
Improving Turn Movement Count Using Cooperative Feedback.
- Published in:
- Sensors (14248220), 2023, v. 23, n. 24, p. 9772, doi. 10.3390/s23249772
- By:
- Publication type:
- Article
A Retrospective Analysis of Long-Term Prophylaxis with Berotralstat in Patients with Hereditary Angioedema and Acquired C1-Inhibitor Deficiency—Real-World Data.
- Published in:
- Clinical Reviews in Allergy & Immunology, 2023, v. 65, n. 3, p. 354, doi. 10.1007/s12016-023-08972-2
- By:
- Publication type:
- Article
Impact of posaconazole and diltiazem on pharmacokinetics of encorafenib, a BRAF V600 kinase inhibitor for melanoma and colorectal cancer with BRAF mutations.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2675, doi. 10.1111/cts.13662
- By:
- Publication type:
- Article
High recurrence rate of eczema herpeticum in moderate/severe atopic dermatitis –TREATgermany registry analysis.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2023, v. 21, n. 12, p. 1490, doi. 10.1111/ddg.15205
- By:
- Publication type:
- Article
Hohe Rezidivrate des Eczema herpeticatum bei mittelschwerer bis schwerer atopischer Dermatitis – eine TREATgermany Registeranalyse.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2023, v. 21, n. 12, p. 1490, doi. 10.1111/ddg.15205_g
- By:
- Publication type:
- Article
Ensuring Networks Work Well: Development of a Self-evaluation Tool for Network Quality in Community Health Promotion.
- Published in:
- Progress in Community Health Partnerships, 2023, v. 17, n. 4, p. 615, doi. 10.1353/cpr.2023.a914118
- By:
- Publication type:
- Article
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 6, p. 939, doi. 10.1007/s40257-023-00806-3
- By:
- Publication type:
- Article
First update of the living European guideline (EuroGuiDerm) on atopic eczema.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 11, p. e1283, doi. 10.1111/jdv.19269
- By:
- Publication type:
- Article
Reference intervals for trace mineral and heavy metal concentrations in horse livers in the Netherlands.
- Published in:
- Journal of Veterinary Diagnostic Investigation, 2023, v. 35, n. 6, p. 737, doi. 10.1177/10406387231193328
- By:
- Publication type:
- Article
A detailed look at the European Medicines Agency's recommendations for use of Janus kinase inhibitors in patients with atopic dermatitis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 10, p. 2041, doi. 10.1111/jdv.19255
- By:
- Publication type:
- Article